✦ LIBER ✦

A Randomized Trial of 1- and 3-Month Depot Leuprolide Doses in the Treatment of Central Precocious Puberty

✍ Scribed by Kimberly Fuld; Carolyn Chi; E. Kirk Neely

Book ID: 113746740
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 533 KB
Volume: 159
Category: Article
ISSN: 1097-6833
DOI: 10.1016/j.jpeds.2011.05.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Leuprolide Acetat

Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty

✍ Lee, P. A.; Klein, K.; Mauras, N.; Neely, E. K.; Bloch, C. A.; Larsen, L.; Matti 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 120 KB

Pharmacokinetic and Exposure–Response An

Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty

✍ Mostafa, Nael M.; Hosmane, Balakrishna; Larsen, Lois M.; Chwalisz, Kristof; Chiu 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 378 KB

Effects of leuprolide in the treatment o

Effects of leuprolide in the treatment of central precocious puberty

✍ Peter A. Lee; John G. Page 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 378 KB

Efficacy of Leuprolide Acetate 1-Month D

Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study

✍ Peter A Lee; E Kirk Neely; John Fuqua; Di Yang; Lois M Larsen; Cynthia Mattia-Go 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 672 KB

Comparison of three doses of leuprolide

Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results

✍ Verónica Mericq; Juan Javier Lammoglia; Nancy Unanue; Claudio Villaroel; María I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

139 EVALUATION OF THE EFFICACY AND SAFET

139 EVALUATION OF THE EFFICACY AND SAFETY OF SWITCHING FROM TREATMENT WITH LEUPROLIDE 1-MONTH DOSING REGIMEN TO DEGARELIX 1-MONTH DOSING REGIMEN IN PROSTATE CANCER (PCA) PATIENTS

✍ J. De La Rosette; R.L. Davis III; B.E. Persson; T.K. Olesen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 81 KB